Detalhe da pesquisa
1.
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study.
Euro Surveill
; 29(15)2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606569
2.
Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-ß-Lactamase VIM-1.
Antimicrob Agents Chemother
; 67(5): e0150522, 2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195077
3.
Simultaneous and divergent evolution of resistance to cephalosporin/ß-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
J Antimicrob Chemother
; 78(5): 1195-1200, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918743
4.
Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel ß-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing Enterobacterales.
Antimicrob Agents Chemother
; 66(2): e0167621, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807754
5.
Selection of AmpC ß-Lactamase Variants and Metallo-ß-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections.
Antimicrob Agents Chemother
; 66(2): e0206721, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930034
6.
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
J Antimicrob Chemother
; 77(10): 2809-2815, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904000
7.
Antimicrobial Diterpene Alkaloids from an Agelas citrina Sponge Collected in the Yucatán Peninsula.
Mar Drugs
; 20(5)2022 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35621949
8.
Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
J Antimicrob Chemother
; 76(1): 91-100, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33083833
9.
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales.
J Antimicrob Chemother
; 76(6): 1498-1510, 2021 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677560
10.
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection.
J Antimicrob Chemother
; 75(11): 3209-3217, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728723
11.
In Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge Agelas dilatata, against Pseudomonas aeruginosa.
Mar Drugs
; 18(6)2020 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32585891
12.
Marine Organisms from the Yucatan Peninsula (Mexico) as a Potential Natural Source of Antibacterial Compounds.
Mar Drugs
; 18(7)2020 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32708418
13.
Reply to Shapiro, "Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum ß-Lactamase-Producing Enterobacterales".
Antimicrob Agents Chemother
; 66(5): e0035322, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35471039
14.
Activity of aztreonam in combination with novel ß-lactamase inhibitors against metallo-ß-lactamase-producing Enterobacterales from Spain.
Int J Antimicrob Agents
; 61(4): 106738, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736925
15.
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification.
Int J Antimicrob Agents
; 62(4): 106935, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541530
16.
Interplay between OXA-10 ß-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales.
Antibiotics (Basel)
; 12(6)2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370318
17.
Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of blaOXA-24/40 and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic Species.
Microbiol Spectr
; 10(1): e0273421, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138195
18.
6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to ß-Lactam Antibiotics.
J Med Chem
; 64(9): 6310-6328, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913328
19.
Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the ß-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.
Antibiotics (Basel)
; 10(2)2021 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33672671
20.
Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae.
Biomed Pharmacother
; 130: 110606, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32795924